Comprehensive Molecular Characterization of Advanced Pancreatic Ductal Adenocarcinomas (PDAC) for Better Treatment Selection: A Prospective Study
Researchers are looking for better ways of understanding and treating pancreatic cancer. The
purpose of this study is to see how useful it is to look for changes and characteristics in
your genes (molecules that contain instructions for the development and functioning of the
cells) and the genes within the tumour. These characteristics may be useful in choosing
treatments for patients in the future. Changes (mutations) in genes have been shown to be an
important characteristic in cancers. Looking at differences in genes in patients with
advanced pancreatic ductal adenocarcinomas and comparing this information with response to
their initial chemotherapy treatment may help to learn which treatments may be better for
certain patients after initial treatment.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society